###begin article-title 0
###xml 46 50 42 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
Inactivation of TIF1gamma Cooperates with KrasG12D to Induce Cystic Tumors of the Pancreas
###end article-title 0
###begin p 1
Current address: The Wistar Institute, Philadelphia, Pennsylvania, United States of America
###end p 1
###begin p 2
Conceived and designed the experiments: DFV SM LB. Performed the experiments: DFV KPY IT FG VA BK FL SM SGL SG JYS RL LB. Analyzed the data: DFV IT VA BK JCM SM JLI PD SG AP RR NB JYS RL LB. Contributed reagents/materials/analysis tools: DFV KPY IT VA JCM NB JYS RL LB. Wrote the paper: RL LB.
###end p 2
###begin p 3
###xml 610 619 596 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif1&#947;</italic>
###xml 644 651 622 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 635 651 617 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif1&#947;<sup>lox/lox</sup></italic>
###xml 679 688 657 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif1&#947;</italic>
###xml 737 744 707 714 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 719 744 693 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 786 790 756 760 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 800 807 766 773 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 769 807 739 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 838 847 804 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif1&#947;</italic>
###xml 914 918 876 880 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 910 918 872 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 941 950 903 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIF1&#947;</italic>
###xml 1025 1034 983 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif1&#947;</italic>
###xml 1105 1109 1059 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras</italic>
###xml 1300 1304 1254 1258 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 1310 1317 1264 1271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 1283 1317 1237 1271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Smad4<sup>lox/lox</sup></italic>
###xml 316 321 <span type="species:ncbi:10090">mouse</span>
###xml 629 633 <span type="species:ncbi:10090">mice</span>
###xml 745 749 <span type="species:ncbi:10090">mice</span>
###xml 808 812 <span type="species:ncbi:10090">mice</span>
###xml 965 970 <span type="species:ncbi:9606">human</span>
###xml 997 1002 <span type="species:ncbi:10090">mouse</span>
###xml 1164 1169 <span type="species:ncbi:9606">human</span>
###xml 1318 1322 <span type="species:ncbi:10090">mice</span>
###xml 1624 1629 <span type="species:ncbi:9606">human</span>
###xml 1742 1747 <span type="species:ncbi:9606">human</span>
Inactivation of the Transforming Growth Factor Beta (TGFbeta) tumor suppressor pathway contributes to the progression of Pancreatic Ductal AdenoCarcinoma (PDAC) since it is inactivated in virtually all cases of this malignancy. Genetic lesions inactivating this pathway contribute to pancreatic tumor progression in mouse models. Transcriptional Intermediary Factor 1 gamma (TIF1gamma) has recently been proposed to be involved in TGFbeta signaling, functioning as either a positive or negative regulator of the pathway. Here, we addressed the role of TIF1gamma in pancreatic carcinogenesis. Using conditional Tif1gamma knockout mice (Tif1gammalox/lox), we selectively abrogated Tif1gamma expression in the pancreas of Pdx1-Cre;Tif1gammalox/lox mice. We also generated Pdx1-Cre;LSL-KrasG12D;Tif1gammalox/lox mice to address the effect of Tif1gamma loss-of-function in precancerous lesions induced by oncogenic KrasG12D. Finally, we analyzed TIF1gamma expression in human pancreatic tumors. In our mouse model, we showed that Tif1gamma was dispensable for normal pancreatic development but cooperated with Kras activation to induce pancreatic tumors reminiscent of human Intraductal Papillary Mucinous Neoplasms (IPMNs). Interestingly, these cystic lesions resemble those observed in Pdx1-Cre;LSL-KrasG12D;Smad4lox/lox mice described by others. However, distinctive characteristics, such as the systematic presence of endocrine pseudo-islets within the papillary projections, suggest that SMAD4 and TIF1gamma don't have strictly redundant functions. Finally, we report that TIF1gamma expression is markedly down-regulated in human pancreatic tumors by quantitative RT-PCR and immunohistochemistry supporting the relevance of these findings to human malignancy. This study suggests that TIF1gamma is critical for tumor suppression in the pancreas, brings new insight into the genetics of pancreatic cancer, and constitutes a promising model to decipher the respective roles of SMAD4 and TIF1gamma in the multifaceted functions of TGFbeta in carcinogenesis and development.
###end p 3
###begin title 4
Author Summary
###end title 4
###begin p 5
###xml 421 430 403 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif1&#947;</italic>
###xml 517 521 495 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KRAS</italic>
###xml 536 540 514 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 532 540 510 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 583 592 561 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif1&#947;</italic>
###xml 690 695 664 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad4</italic>
###xml 440 444 <span type="species:ncbi:10090">mice</span>
###xml 563 571 <span type="species:ncbi:9606">patients</span>
###xml 932 937 <span type="species:ncbi:9606">human</span>
###xml 1000 1005 <span type="species:ncbi:9606">human</span>
Inactivation of the TGFbeta tumor suppressor pathway contributes to the progression of Pancreatic Ductal AdenoCarcinoma (PDAC), a devastating malignancy. Transcriptional Intermediary Factor 1gamma (TIF1gamma) has recently been proposed to be involved in TGFbeta signaling, a pathway inactivated in virtually all cases of this malignancy. To address the role of TIF1gamma in pancreatic carcinogenesis, we used conditional Tif1gamma knockout mice. In a genetic background expressing a constitutively active mutation of KRAS oncogene (KrasG12D) recurrently found in patients with PDAC, Tif1gamma inactivation induces pancreatic precancerous lesions resembling those observed in the absence of Smad4, a key player involved TGFbeta signal transduction. This observation strengthens the notion that TIF1gamma plays an active role in TGFbeta signaling. Interestingly, we also found that TIF1gamma expression was markedly down-regulated in human pancreatic tumors supporting the relevance of our findings to human malignancy. Characterization of new players involved in the outbreak of early pancreatic lesions that will eventually evolve into invasive pancreatic cancer is crucial to detect the disease earlier and eventually develop new therapeutic drugs.
###end p 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 323 326 323 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Maitra1">[1]</xref>
###xml 647 650 647 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Maitra2">[2]</xref>
###xml 1227 1230 1227 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Furukawa1">[3]</xref>
###xml 354 362 <span type="species:ncbi:9606">patients</span>
Pancreatic Ductal AdenoCarcinoma (PDAC), characterized by a ductal cell-type differentiation pattern, is the most common type of pancreatic cancer, accounting for more than 85% of pancreatic neoplasms. PDAC is the fourth leading cause of cancer-related mortality and carries an overall 5-year-survival rate of less than 5% [1]. The poor outcome of these patients is due to late diagnosis and resistance to current therapies. PDAC appears to arise from precursor lesions known as Pancreatic Intraepithelial Neoplasia (PanINs) or from two types of cystic tumors: Mucinous Cystic Neoplasms (MCNs) and Intraductal Papillary Mucinous Neoplasms (IPMNs) [2]. Mucinous cystic neoplasms are cysts lined by mucin-producing epithelial cells usually associated with an ovarian-type of stroma. These cysts do not communicate with the larger pancreatic ducts. IPMNs form intraductal papillary projections replacing the normal duct epithelium, secrete mucin, and communicate with ducts. IPMNs are currently classified according to their pattern of apparent histological differentiation into three main subtypes: intestinal (with the neoplastic epithelium resembling the intestinal epithelium), the most frequent, pancreatobiliary and gastric [3].
###end p 7
###begin p 8
###xml 65 68 65 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Koorstra1">[4]</xref>
###xml 69 72 69 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Bardeesy1">[5]</xref>
###xml 171 175 171 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KRAS</italic>
###xml 225 234 225 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4A/ARF</italic>
###xml 252 256 252 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 277 287 277 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMAD4/DPC4</italic>
###xml 688 693 688 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
###xml 695 700 695 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4A</italic>
###xml 702 712 702 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STK11/LKB1</italic>
###xml 714 719 714 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRSS1</italic>
###xml 721 726 721 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMLH1</italic>
###xml 731 736 731 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMSH2</italic>
###xml 738 741 738 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Maitra1">[1]</xref>
###xml 742 745 742 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Shi1">[6]</xref>
###xml 54 59 <span type="species:ncbi:9606">human</span>
Recurrent genetic alterations have been identified in human PDAC [4],[5]. Sporadic cases, which represent the vast majority of PDAC, are associated with activation of the KRAS oncogene (>90% of cases) and inactivation of the INK4A/ARF (>80% of cases), TP53 (>50% of cases) and SMAD4/DPC4 (>50% of cases) tumor suppressors. Inherited pancreatic cancers represent approximately 5-10% of all pancreatic cancers. In a high proportion of familial pancreatic cancers, the genetic alterations causing the disease are still unknown. However, several germinal mutations associated with complex familial syndromes have been shown to significantly increase the risk of developing pancreatic cancer (BRCA2, INK4A, STK11/LKB1, PRSS1, hMLH1 and hMSH2) [1],[6].
###end p 8
###begin p 9
###xml 140 143 140 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Hruban1">[7]</xref>
###xml 222 226 222 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 234 238 234 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12V</sup>
###xml 293 296 293 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Hingorani1">[8]</xref>
###xml 297 300 297 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Guerra1">[9]</xref>
###xml 301 305 301 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Grippo1">[10]</xref>
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Hingorani2">[11]</xref>
###xml 390 394 390 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Aguirre1">[12]</xref>
###xml 395 399 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Bardeesy2">[13]</xref>
###xml 414 418 411 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Ijichi1">[14]</xref>
###xml 496 500 493 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Hezel1">[15]</xref>
###xml 501 505 498 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Shi2">[19]</xref>
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
In the last five years, a series of genetically engineered mouse models of PDAC have been developed based on these signature gene mutations [7]. For instance, expression of a constitutively active Kras mutant protein (KrasG12D or KrasG12V) induces PanINs that eventually progress towards PDAC [8],[9],[10]. Kras activated mutants act in concert with inactivation of the p53 [11], Ink4A/Arf [12],[13], and TbetaRII [14] tumor suppressors to accelerate development of PDAC. These models and others [15]-[19] support the concept that progression towards invasive PDAC involves emergence from different precancerous lesions (PanINs, MCNs and IPMNs) depending on the associated genetic alterations.
###end p 9
###begin p 10
###xml 152 156 149 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Jones1">[20]</xref>
###xml 225 230 222 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad4</italic>
###xml 234 242 231 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T&#946;RII</italic>
###xml 277 282 271 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad7</italic>
###xml 343 347 337 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Ijichi1">[14]</xref>
###xml 349 353 343 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Bardeesy3">[21]</xref>
###xml 354 358 348 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Kuang1">[24]</xref>
###xml 555 559 543 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Ross1">[25]</xref>
###xml 560 564 548 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Massague1">[26]</xref>
###xml 330 335 <span type="species:ncbi:10090">mouse</span>
The TGFbeta pathway appears to be of particular importance to PDAC tumor suppression, since it is inactivated in virtually all cases of this malignancy [20], and since genetic lesions inactivating the pathway-inactivation of Smad4 or TbetaRII and over-expression of inhibitory Smad7- contribute to pancreatic tumor progression in mouse models [14], [21]-[24]. Transforming growth factor beta (TGFbeta) is a secreted polypeptide belonging to a wide family of cytokines and growth factors including TGFbetas, Bone Morphogenetic Proteins (BMPs) and activins [25],[26]. Upon binding to its receptors, TGFbeta triggers phosphorylation of the SMAD2 and SMAD3 transcription factors. Phosphorylated SMAD2 and SMAD3 then interact with SMAD4. The SMAD2/3/4 complex accumulates within the nucleus, binds to DNA and activates the transcription of target genes leading to proliferative arrest or apoptosis of epithelial cells.
###end p 10
###begin p 11
###xml 95 99 91 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Venturini1">[27]</xref>
###xml 100 104 96 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Yan1">[28]</xref>
###xml 355 359 344 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Dupont1">[29]</xref>
###xml 360 364 349 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Dupont2">[30]</xref>
###xml 365 369 354 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Levy1">[31]</xref>
###xml 539 543 521 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-He1">[32]</xref>
Transcriptional Intermediary Factor 1 gamma (also named TIF1gamma/TRIM33/RFG7/PTC7/Ectodermin) [27],[28] appears to contribute to TGFbeta signaling, although its precise functional role is not clear. Some data point toward TIF1gamma as a negative regulator of the pathway through its capacity to mono-ubiquinate SMAD4 and limit SMAD4 nuclear accumulation [29],[30],[31]. In contrast, other studies have suggested that TIF1gamma plays an important positive role in transducing TGFbeta signaling through its interaction with SMAD2 and SMAD3 [32].
###end p 11
###begin p 12
###xml 331 340 321 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif1&#947;</italic>
###xml 405 409 391 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 401 409 387 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 500 509 486 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIF1&#947;</italic>
###xml 285 290 <span type="species:ncbi:10090">mouse</span>
###xml 467 472 <span type="species:ncbi:9606">human</span>
###xml 542 547 <span type="species:ncbi:9606">human</span>
###xml 622 627 <span type="species:ncbi:10090">mouse</span>
###xml 637 642 <span type="species:ncbi:9606">human</span>
Here we wished to determine whether TIF1gamma contributes to tumorigenesis consistent with a function within the TGFbeta signaling pathway. We have focused on pancreatic exocrine tumors based on the prominent role played by TGFbeta signaling in these malignancies. Using a conditional mouse strain, we show for the first time that Tif1gamma is an important gene whose loss of function cooperates with KrasG12D activation to induce cystic pancreatic tumors resembling human IPMNs. We also report that TIF1gamma expression is down-regulated in human PDAC and some types of precursor lesions, supporting the relevance of our mouse model to human malignancy.
###end p 12
###begin title 13
Results/Discussion
###end title 13
###begin p 14
###xml 24 33 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif1&#947;</italic>
###xml 85 89 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif1</italic>
###xml 109 113 101 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Doisne1">[33]</xref>
###xml 119 127 111 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre</italic>
###xml 133 137 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Gu1">[34]</xref>
###xml 139 143 131 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1</italic>
###xml 250 258 242 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre</italic>
###xml 404 408 396 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Jorgensen1">[35]</xref>
###xml 428 435 416 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 410 435 402 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 877 884 861 868 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 859 884 847 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 1149 1156 1125 1132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 1131 1156 1111 1132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 1167 1176 1143 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000575.s001">Figure S1</xref>
###xml 1216 1225 1192 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif1&#947;</italic>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
###xml 259 274 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1087 1091 <span type="species:ncbi:10090">mice</span>
###xml 1295 1300 <span type="species:ncbi:10090">mouse</span>
To selectively abrogate Tif1gamma expression in the pancreas, we crossed conditional Tif1gamma knockout mice [33] with Pdx1-Cre mice [34]. Pdx1 is a gene expressed in the common progenitor to all pancreatic lineages during early embryogenesis, hence Pdx1-Cre transgenic mice exhibit recombination of floxed alleles in pancreatic cells from all lineages (endocrine, acinar, centroacinar and ductal cells) [35]. Pdx1-Cre;Tif1gammalox/lox animals were born at expected ratios and showed normal lifespan without obvious developmental or physiological alterations. Live imaging techniques (Positron Emission Tomography, PET and Magnetic Resonance Imaging, MRI), histological techniques (immunodetection of insulin, glucagon, PPY, chymotrypsine, F4/80, CD3, MPO), metabolic tests (glucose tolerance) did not reveal any significant differences between wild-type and Pdx1-Cre;Tif1gammalox/lox littermates (n>20, between 3 weeks and 2 years of age) (data not shown). As expected, immunohistochemistry experiments showed that Tif1gamma was expressed in the nuclei of pancreatic cells in wild-type mice and that this staining was lost in the Pdx1-Cre;Tif1gammalox/lox pancreas (Figure S1). In all, these observations show that Tif1gamma is dispensable for normal pancreatic development and function in the mouse.
###end p 14
###begin p 15
###xml 11 15 11 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KRAS</italic>
###xml 124 127 124 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Hingorani1">[8]</xref>
###xml 128 132 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Grippo1">[10]</xref>
###xml 133 137 133 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Aguirre1">[12]</xref>
###xml 161 170 161 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif1&#947;</italic>
###xml 263 267 259 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 259 267 255 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 312 316 308 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 326 333 318 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 295 333 291 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 348 356 340 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000575.s005">Table S1</xref>
###xml 549 556 541 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 651 655 643 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 665 672 657 664 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 634 672 626 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Ink4A/Arf<sup>lox/lox</sup></italic>
###xml 808 812 800 804 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 822 829 810 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 791 829 783 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 1055 1064 1043 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g001">Figure 1B</xref>
###xml 1142 1146 1130 1134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 1125 1146 1113 1134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup></italic>
###xml 1156 1165 1144 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g001">Figure 1A</xref>
###xml 1234 1238 1222 1226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 1248 1255 1236 1243 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 1217 1255 1205 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Ink4A/Arf<sup>lox/lox</sup></italic>
###xml 1367 1376 1355 1364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g001">Figure 1C</xref>
###xml 1474 1483 1462 1471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g001">Figure 1D</xref>
###xml 1506 1510 1494 1498 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 1520 1527 1504 1511 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 1489 1527 1477 1511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 1534 1543 1518 1527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g001">Figure 1E</xref>
###xml 1570 1574 1554 1558 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 1584 1591 1568 1575 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 1553 1591 1537 1575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Ink4A/Arf<sup>lox/lox</sup></italic>
###xml 1663 1672 1647 1656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g001">Figure 1F</xref>
###xml 1720 1724 1704 1708 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 1734 1741 1714 1721 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 1703 1741 1687 1721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 1871 1880 1851 1860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g001">Figure 1H</xref>
###xml 1885 1894 1865 1874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000575.s002">Figure S2</xref>
###xml 1937 1941 1917 1921 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 1951 1958 1931 1938 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 1920 1958 1900 1938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Ink4A/Arf<sup>lox/lox</sup></italic>
###xml 2008 2017 1988 1997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g001">Figure 1I</xref>
###xml 2071 2075 2051 2055 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 2054 2075 2034 2055 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup></italic>
###xml 2121 2130 2101 2110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g001">Figure 1G</xref>
###xml 2204 2208 2184 2188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 2218 2225 2194 2201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 2187 2225 2167 2201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 2289 2298 2265 2274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g001">Figure 1K</xref>
###xml 2433 2437 2409 2413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 2447 2454 2423 2430 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 2416 2454 2392 2430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Ink4A/Arf<sup>lox/lox</sup></italic>
###xml 2456 2465 2432 2441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g001">Figure 1L</xref>
###xml 2521 2525 2497 2501 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 2535 2542 2507 2514 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 2504 2542 2480 2514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 2552 2560 2524 2532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000575.s005">Table S1</xref>
###xml 2677 2681 2649 2653 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 2660 2681 2632 2653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup></italic>
###xml 2847 2851 2819 2823 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 2861 2868 2829 2836 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 2830 2868 2802 2836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 2935 2939 2903 2907 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 2918 2939 2886 2907 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup></italic>
###xml 2946 2954 2914 2922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000575.s005">Table S1</xref>
###xml 3014 3023 2982 2987 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif1&#947;</italic>
###xml 3063 3067 3027 3031 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 3059 3067 3023 3031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 41 46 <span type="species:ncbi:9606">human</span>
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
###xml 334 338 <span type="species:ncbi:10090">mice</span>
###xml 586 590 <span type="species:ncbi:10090">mice</span>
###xml 673 677 <span type="species:ncbi:10090">mice</span>
###xml 1256 1260 <span type="species:ncbi:10090">mice</span>
###xml 1528 1532 <span type="species:ncbi:10090">mice</span>
###xml 1592 1596 <span type="species:ncbi:10090">mice</span>
###xml 1959 1963 <span type="species:ncbi:10090">mice</span>
###xml 2619 2623 <span type="species:ncbi:10090">mice</span>
###xml 2869 2873 <span type="species:ncbi:10090">mice</span>
###xml 2940 2944 <span type="species:ncbi:10090">mice</span>
Activating KRAS mutations occur early in human PDAC pathogenesis and give rise to slowly progressing PanINs in mouse models [8],[10],[12]. We then asked whether Tif1gamma inactivation could modify the phenotype or latency of the pancreatic lesions induced by KrasG12D. To that end, we generated Pdx1-Cre;LSL-KrasG12D;Tif1gammalox/lox mice (n = 12, Table S1). All animals looked healthy at the time they were euthanized (the oldest animal was sacrificed at the age of 189 days). Since pancreatic lesions are often asymptomatic, we decided to explore in vivo the pancreas of these mutant mice (n = 4) by PET and MRI imaging techniques. Pdx1-Cre;LSL-KrasG12D;Ink4A/Arflox/lox mice, which exhibit rapid PDAC progression, were also employed in these studies. Strikingly, MRI imaging performed on Pdx1-Cre;LSL-KrasG12D;Tif1gammalox/lox animals revealed an hypertrophic pancreas with multifocal cystic lesions exhibiting T2 hypersignals visible as early as 7 weeks after birth (T2 weighted scans allow detection of cysts as they are sensitive to water content) (Figure 1B). Such lesions were absent in the pancreas of wild-type and Pdx1-Cre;LSL-KrasG12D animals (Figure 1A) and were clearly different from those observed in Pdx1-Cre;LSL-KrasG12D;Ink4A/Arflox/lox mice, which harbor solid tumors exhibiting a T1 isosignals (T1 weighed scans allow detection of solid tumors) (Figure 1C). PET imaging did not show significant increased metabolic activity in the abdomen of wild-type (Figure 1D) and Pdx1-Cre;LSL-KrasG12D;Tif1gammalox/lox mice (Figure 1E) whereas Pdx1-Cre;LSL-KrasG12D;Ink4A/Arflox/lox mice had abdominal lesions with readily detectable metabolic activity (Figure 1F). Macroscopic analysis of the Pdx1-Cre;LSL-KrasG12D;Tif1gammalox/lox pancreas confirmed the presence of numerous cysts affecting the entire organ without macroscopic evidence of invasive carcinoma (Figure 1H and Figure S2) whereas the pancreas of Pdx1-Cre;LSL-KrasG12D;Ink4A/Arflox/lox mice was invaded by a firm and homogeneous mass (Figure 1I) and the pancreas from wild-type or Pdx1-Cre;LSL-KrasG12D animals had a normal macroscopic appearance (Figure 1G). The size of these cysts observed in the pancreas from Pdx1-Cre;LSL-KrasG12D;Tif1gammalox/lox was variable and most of them contained papillary projections (Figure 1K). These lesions clearly contrast with the invasive tumors of ductal morphology identified as PDAC in the pancreas of Pdx1-Cre;LSL-KrasG12D;Ink4A/Arflox/lox (Figure 1L). The histological analysis of the 12 Pdx1-Cre;LSL-KrasG12D;Tif1gammalox/lox animals (Table S1) revealed the presence of cystic lesions in 100% of these mice, such cysts being never observed in Pdx1-Cre;LSL-KrasG12D or wild type control animals. Quantitative analysis revealed that the area occupied by the abnormal pancreas exceeded 50% by the age 6 weeks in 6/7 Pdx1-Cre;LSL-KrasG12D;Tif1gammalox/lox mice whereas it represented less than 20% in 6/6 Pdx1-Cre;LSL-KrasG12D mice (Table S1). Collectively these data demonstrate that inactivation of Tif1gamma actively cooperates with activated KrasG12D to induce cystic tumors of the pancreas.
###end p 15
###begin title 16
###xml 23 32 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif1&#947;</italic>
###xml 63 67 59 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 59 67 55 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
Homozygous deletion of Tif1gamma cooperates with activated KrasG12D mutation to induce cystic tumors of the pancreas.
###end title 16
###begin p 17
###xml 371 375 371 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 385 392 381 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 354 392 354 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 462 466 <span type="species:ncbi:10090">mice</span>
Magnetic Resonance Imaging (MRI) (A-C). Positron Emission Tomography (PET) (D-F). Gross anatomy of the pancreas after dissection (G-I). Hematoxylin Phloxine Saffron (HPS) staining of pancreas sections (J-L). Acinar tissue (stars), scattered endocrine islets (arrow) and exocrine ducts (arrowhead). When notified, pancreas is circled in red dashed lines. Pdx1-Cre;LSL-KrasG12D;Tif1gammalox/lox used in this experiment was 154 days old and representative of the 4 mice we analyzed at the age of 18-27 weeks.
###end p 17
###begin p 18
###xml 73 77 73 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 87 94 83 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 56 94 56 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 121 125 117 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 104 125 100 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup></italic>
###xml 248 256 244 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000575.s005">Table S1</xref>
###xml 287 299 283 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g002">Figure 2A&#8211;2D</xref>
###xml 319 323 315 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 302 323 298 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup></italic>
###xml 392 404 388 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g002">Figure 2E&#8211;2H</xref>
###xml 439 443 435 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 453 460 445 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 422 460 418 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 623 632 615 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g002">Figure 2I</xref>
###xml 637 646 629 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000575.s003">Figure S3</xref>
###xml 786 798 778 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g002">Figure 2J&#8211;2L</xref>
###xml 938 942 930 934 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 952 959 940 947 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 921 959 913 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 1236 1248 1224 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g002">Figure 2I&#8211;2L</xref>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 324 328 <span type="species:ncbi:10090">mice</span>
###xml 960 964 <span type="species:ncbi:10090">mice</span>
To carefully compare the pancreatic lesions observed in Pdx1-Cre;LSL-KrasG12D;Tif1gammalox/lox with the Pdx1-Cre;LSL-KrasG12D controls, we performed a sequential histological analysis of pancreas from animals (n = 12) euthanized at different ages (Table S1). Contrary to wild-type mice (Figure 2A-2D), Pdx1-Cre;LSL-KrasG12D mice gradually developed focal PanINs by the age of about 10 weeks (Figure 2E-2H). Strikingly, in Pdx1-Cre;LSL-KrasG12D;Tif1gammalox/lox pancreas, PanINs, signs of acute inflammation as well as enlarged and dilated ductal structure resembling budding cysts were observed as early as 3 weeks of age (Figure 2I and Figure S3). At later time points, inflammatory tissue and PanINs were mainly replaced with cystic lesions becoming more numerous and of larger size (Figure 2J-2L). Microscopic examination revealed that the lining of the cystic structures characteristically found in the pancreas from Pdx1-Cre;LSL-KrasG12D;Tif1gammalox/lox mice was formed by epithelial cells with a cuboidal or cylindrical morphology. These cells formed numerous thick papillary projections in the cyst lumen. The axis of these projections usually contained masses of small monomorphic cells with an endocrine morphology (Insets in Figure 2I-2L).
###end p 18
###begin title 19
###xml 16 25 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif1&#947;</italic>
###xml 52 56 48 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 48 56 44 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
Inactivation of Tif1gamma accelerates activated KrasG12D-mediated pancreatic neoplasia.
###end title 19
###begin p 20
###xml 46 50 46 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 29 50 29 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup></italic>
###xml 78 82 78 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 92 99 88 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 61 99 61 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
Sections of wild-type (A-D), Pdx1-Cre;LSL-KrasG12D (E-H) and Pdx1-Cre;LSL-KrasG12D;Tif1gammalox/lox (I-L) pancreas from mice at different ages were stained with HPS. Number of mice: 3 weeks, n = 3; 6-13 weeks, n = 5; 18-27 weeks, n = 4. Inset pictures: Higher magnification.
###end p 20
###begin p 21
###xml 306 310 306 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 320 327 316 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 289 327 289 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 334 342 330 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g003">Figure 3</xref>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
###xml 328 332 <span type="species:ncbi:10090">mice</span>
We performed immunohistochemical studies to characterized the evolving pancreatic lesions in these mice. We observed staining for chymotrypsin and insulin, which decreased with age, indicating a replacement of exocrine and endocrine components, together with abnormal ductal structures in Pdx1-Cre;LSL-KrasG12D;Tif1gammalox/lox mice (Figure 3). There was a notable disappearance of well-organized endocrine islets with age coinciding with the accumulation of endocrine cells within the papillary projections bulging within the lumen of the cysts.
###end p 21
###begin title 22
###xml 84 88 84 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 98 105 94 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 67 105 67 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
Endocrine and exocrine compartments destruction in the pancreas of Pdx1-Cre;LSL-KrasG12D;Tif1gammalox/lox mice.
###end title 22
###begin p 23
###xml 39 43 39 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 54 61 50 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 21 61 21 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre; LSL-Kras<sup>G12D</sup>; Tif1&#947;<sup>lox/lox</sup></italic>
###xml 333 337 329 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 347 354 339 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 316 354 312 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
###xml 414 418 <span type="species:ncbi:10090">mice</span>
###xml 541 546 <span type="species:ncbi:10090">mouse</span>
Wild-type (A-C') and Pdx1-Cre; LSL-KrasG12D; Tif1gammalox/lox (D-L') pancreas sections were stained with HPS (A,D,G,J), immuno-revealed either with an anti-chymotrypsin antibody (B,E,H,K) or an anti-insulin antibody (C,F,I,L and C',F',I',L' that represent the boxed region in C,F,I,L at a higher magnification). For Pdx1-Cre;LSL-KrasG12D;Tif1gammalox/lox mice, analysis were performed at different ages. Number of mice: 3 weeks, n = 3; 6-13 weeks, n = 5; 18-27 weeks, n = 4. Boxes: Higher magnification. The pictures show one representative mouse for each group.
###end p 23
###begin p 24
###xml 214 218 210 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 228 235 220 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 197 235 193 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 242 251 234 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g004">Figure 4E</xref>
###xml 306 315 298 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g004">Figure 4A</xref>
###xml 434 443 426 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g004">Figure 4B</xref>
###xml 547 551 539 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 561 568 549 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 530 568 522 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 598 607 586 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g004">Figure 4F</xref>
###xml 739 748 727 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g004">Figure 4C</xref>
###xml 829 838 817 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g004">Figure 4G</xref>
###xml 1197 1201 1185 1189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 1211 1218 1195 1202 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 1180 1218 1168 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 1376 1379 1360 1363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Hruban1">[7]</xref>
###xml 236 240 <span type="species:ncbi:10090">mice</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 569 573 <span type="species:ncbi:10090">mice</span>
###xml 1128 1133 <span type="species:ncbi:9606">human</span>
###xml 1219 1223 <span type="species:ncbi:10090">mice</span>
To more precisely identify the nature of these lesions, several lineage markers were explored by immunohistochemistry. We first verified that Tif1gamma expression was lost in pancreatic ducts from Pdx1-Cre;LSL-KrasG12D;Tif1gammalox/lox mice (Figure 4E) compared to normal observed ducts in wild-type mice (Figure 4A). In the normal pancreas, cytokeratin 19 (CK19) is specifically expressed by ductal cells lining the secretory ducts (Figure 4B). We verified that most of the epithelial cells lining the cystic lesions observed in Pdx1-Cre;LSL-KrasG12D;Tif1gammalox/lox mice were positive for CK19 (Figure 4F); this is consistent with a ductal phenotype for these cells. However, in contrast to the cells lining the normal secretory ducts (Figure 4C), many cells lining the cysts were mucus-secreting and stained for Alcian blue (Figure 4G). The cells with an endocrine appearance present within the intra-cystic papillary projections were CK19 and Alcian blue negative. There was no evidence of ovarian-type stroma or of invasive or microinvasive carcinoma, even on serial sections, suggesting that these cystic tumors resemble human IPMNs. In all, the cystic lesions observed in Pdx1-Cre;LSL-KrasG12D;Tif1gammalox/lox mice show distinctive characteristics, including the presence of intra-epithelial endocrine pseudo-islets, suggestive of a mixed, endocrine-exocrine, lesion [7].
###end p 24
###begin title 25
###xml 65 69 65 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 79 86 75 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 48 86 48 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
Immunophenotyping of pancreas cysts observed in Pdx1-Cre;LSL-KrasG12D;Tif1gammalox/lox mice.
###end title 25
###begin p 26
###xml 38 45 34 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 54 58 50 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 20 58 20 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;Tif1&#947;<sup>lox/lox</sup>;LSL-Kras<sup>G12D</sup></italic>
###xml 225 230 <span type="species:ncbi:10090">mouse</span>
Wild-type (A-D) and Pdx1-Cre;Tif1gammalox/lox;LSL-KrasG12D (E-H) pancreas sections were stained to detect glandular cells (CK19), mucus-secreting cells (Alcian Blue), Tif1gamma and Smad4. The pictures show one representative mouse at the age of 22 weeks.
###end p 26
###begin p 27
###xml 73 77 66 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Dupont1">[29]</xref>
###xml 78 82 71 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-He1">[32]</xref>
###xml 141 145 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Bardeesy3">[21]</xref>
###xml 146 150 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Kojima1">[23]</xref>
###xml 159 163 152 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Izeradjene1">[22]</xref>
###xml 194 198 187 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 204 211 197 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 177 211 170 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Smad4<sup>lox/lox</sup></italic>
###xml 277 281 270 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 291 298 280 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 260 298 253 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 632 636 610 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 646 653 620 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 615 653 593 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 723 732 697 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g004">Figure 4H</xref>
###xml 754 763 728 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g004">Figure 4D</xref>
###xml 801 805 775 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 815 822 785 792 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 784 822 758 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 929 933 899 903 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 939 946 909 916 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 912 946 882 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Smad4<sup>lox/lox</sup></italic>
###xml 952 956 922 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Bardeesy3">[21]</xref>
###xml 957 961 927 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Kojima1">[23]</xref>
###xml 212 216 <span type="species:ncbi:10090">mice</span>
###xml 299 303 <span type="species:ncbi:10090">mice</span>
###xml 654 658 <span type="species:ncbi:10090">mice</span>
###xml 823 827 <span type="species:ncbi:10090">mice</span>
###xml 947 951 <span type="species:ncbi:10090">mice</span>
TIF1gamma has recently been proposed to be involved in TGFbeta signaling [29],[32]. The resemblance between the cystic lesions (either IPMNs [21],[23] or MCNs [22]) observed in Pdx1-Cre;LSL-KrasG12D;Smad4lox/lox mice, and the cystic lesions we observed in the Pdx1-Cre;LSL-KrasG12D;Tif1gammalox/lox mice, reinforces an active role of TIF1gamma in TGFbeta signaling. However, we cannot rule out the possibility that TIF1gamma could also be involved in other signaling pathways. Interestingly, we observed that Smad4 expression was almost undetectable in epithelial cells lining the papillary projections observed in Pdx1-Cre;LSL-KrasG12D;Tif1gammalox/lox mice whereas it was detectable in epithelial cells lining the cysts (Figure 4H) or in normal ducts (Figure 4D). IPMNs observed in Pdx1-Cre;LSL-KrasG12D;Tif1gammalox/lox mice always contain a significant endocrine component, a rare event in IPMNs observed in Pdx1-Cre;LSL-KrasG12D;Smad4lox/lox mice [21],[23]. This observation suggests that TIF1gamma and SMAD4 could differentially regulate endocrine versus exocrine differentiation in a context of an activated KRAS oncogenic protein.
###end p 27
###begin p 28
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras</italic>
###xml 69 78 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif1&#947;</italic>
###xml 169 178 165 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIF1&#947;</italic>
###xml 324 333 316 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIF1&#947;</italic>
###xml 338 343 326 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMAD4</italic>
###xml 627 636 615 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIF1&#947;</italic>
###xml 725 726 709 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 738 747 722 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g005">Figure 5A</xref>
###xml 767 776 751 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIF1&#947;</italic>
###xml 908 917 888 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIF1&#947;</italic>
###xml 1018 1027 994 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g005">Figure 5B</xref>
###xml 1287 1296 1255 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g005">Figure 5C</xref>
###xml 1803 1812 1755 1764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g005">Figure 5D</xref>
###xml 1860 1869 1808 1817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g005">Figure 5E</xref>
###xml 1977 1980 1925 1928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Furukawa1">[3]</xref>
###xml 2287 2296 2231 2240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g005">Figure 5F</xref>
###xml 2556 2565 2496 2505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g005">Figure 5G</xref>
###xml 2731 2740 2667 2676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000575-g005">Figure 5H</xref>
###xml 2784 2789 2720 2725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMAD4</italic>
###xml 2904 2913 2840 2849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000575.s004">Figure S4</xref>
###xml 137 142 <span type="species:ncbi:10090">mouse</span>
###xml 215 220 <span type="species:ncbi:9606">human</span>
###xml 506 514 <span type="species:ncbi:9606">patients</span>
###xml 868 875 <span type="species:ncbi:9606">patient</span>
###xml 969 977 <span type="species:ncbi:9606">patients</span>
###xml 1009 1016 <span type="species:ncbi:9606">patient</span>
###xml 1114 1119 <span type="species:ncbi:9606">human</span>
###xml 1898 1906 <span type="species:ncbi:9606">patients</span>
###xml 2326 2334 <span type="species:ncbi:9606">patients</span>
Based on the prominent cooperation noted between Kras activation and Tif1gamma inactivation in promoting cystic pancreatic tumors in our mouse model, we speculated that TIF1gamma expression may be down-regulated in human pancreatic tumors. To test this hypothesis, we analyzed by quantitative RT-PCR the expression level of TIF1gamma and SMAD4 mRNA in 20 PDAC and 16 peritumoral tissues coming from surgical specimens removed for therapeutic purposes (peritumoral tissues were not available for 4 of these patients). The cellularity of the samples used for molecular analysis was verified histologically. Our results show that TIF1gamma expression is significantly decreased in the tumors as compared to peritumoral tissues (P = 0.0054) (Figure 5A). We also compared TIF1gamma expression levels in each individual tumor along with the peritumoral tissue from the same patient (n = 16). Our results show that TIF1gamma expression is significantly down-regulated in most patients and is not up-regulated in any patient (Figure 5B). We next examined TIF1gamma protein pattern of expression by immunohistochemistry in human pancreatic cancers and their precursors. In peritumoral tissues from PDAC, TIF1gamma was detected in the majority of the nuclei of acinar, ductal and endocrine cells (Figure 5C). Centroacinar cells are more difficult to identify in routinely stained sections; however, since no epithelial cell population devoid of TIF1gamma expression has been detected in the normal pancreas, it can be assumed that they also express TIF1gamma. In PDAC (16 cases), TIF1gamma nuclear expression level was significantly decreased as compared to the peritumoral tissue. In 8 cases, TIF1gamma expression was heterogeneous, with large numbers of negative cells coexisting with scattered positive cells (Figure 5D). In 2 cases, TIF1gamma was even undetectable (Figure 5E). In IPMNs (samples from 10 patients, all with the intestinal subtype according to current classifications [3]), almost all neoplastic cells in areas of low grade dysplasia (present in the 10 cases) displayed a weak nuclear positivity whereas in areas of high grade dysplasia (present in the 10 cases), more than 50% of cells were negative for TIF1gamma; this was especially the case along the papillary projections (Figure 5F). In PanINs (samples from 15 patients, with grade 1 in 12, grade 2 in 10 and grade 3 in 8), the expression of TIF1gamma was usually retained in grade 1 and 2 lesions (data not shown), but was undetectable in a variable proportion of cells in grade 3 lesions (Figure 5G). In MCNs (8 cases), TIF1gamma protein was strongly expressed by all neoplastic cells, even in areas of high grade dysplasia and in foci of microinvasive carcinoma (Figure 5H). We showed in the same set of tumors that SMAD4 expression was also down-regulated in high-grade PanINs, IPMNs and PDAC, while remained highly expressed in MCNs (Figure S4).
###end p 28
###begin title 29
###xml 0 9 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIF1&#947;</italic>
###xml 24 29 <span type="species:ncbi:9606">human</span>
TIF1gamma expression in human pancreatic neoplasia.
###end title 29
###begin p 30
###xml 18 27 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIF1&#947;</italic>
###xml 36 41 <span type="species:ncbi:9606">human</span>
###xml 441 449 <span type="species:ncbi:9606">patients</span>
###xml 509 517 <span type="species:ncbi:9606">patients</span>
###xml 574 582 <span type="species:ncbi:9606">patients</span>
###xml 603 611 <span type="species:ncbi:9606">patients</span>
The expression of TIF1gamma from 20 human PDAC and 16 peritumoral tissues was determined by quantitative RT-PCR (A). The average expression (+/-sd) is plotted for each group (B). The significance (P value) for the difference between peritumoral and tumoral groups, determined by a Student's T test, is shown above the graphs. The expression of TIF1gamma protein was evaluated by immunohistochemistry in different pancreatic lesions: PDAC (n patients = 20) (peritumoral (C) and tumoral tissues (D, E). IPMN (n patients = 10) of high grade dysplasia (F), high-grade PanINs (n patients = 8) (G) and MCN (n patients = 15) (H). Inset pictures: higher magnification.
###end p 30
###begin p 31
###xml 29 33 29 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 43 50 39 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 12 50 12 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 280 283 276 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Furukawa1">[3]</xref>
###xml 340 344 336 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 350 357 346 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 323 357 319 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Smad4<sup>lox/lox</sup></italic>
###xml 416 420 412 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Bardeesy3">[21]</xref>
###xml 465 469 461 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 475 482 471 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 448 482 444 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Smad4<sup>lox/lox</sup></italic>
###xml 540 544 536 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Kojima1">[23]</xref>
###xml 782 786 778 782 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 796 803 788 795 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 765 803 761 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;LSL-Kras<sup>G12D</sup>;Tif1&#947;<sup>lox/lox</sup></italic>
###xml 1067 1071 1059 1063 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 1063 1071 1055 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 1085 1094 1077 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif1&#947;</italic>
###xml 1315 1319 1297 1301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Erdogan1">[36]</xref>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 211 217 <span type="species:ncbi:9606">humans</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 804 808 <span type="species:ncbi:10090">mice</span>
None of the Pdx1-Cre;LSL-KrasG12D;Tif1gammalox/lox mice (n = 4) sacrificed after the age of 13 weeks showed an aggressive cancer developed from IPMNs. This observation is consistent with epidemiological data in humans showing that IPMNs only rarely give rise to aggressive tumors [3]. Interestingly, IPMNs were reported in Pdx1-Cre;LSL-KrasG12D;Smad4lox/lox mice but no PDAC was found by the age of 13 weeks (n = 8) [21]. Another group observed in Pdx1-Cre;LSL-KrasG12D;Smad4lox/lox a significant proportion of PDAC between 23 and 33 weeks [23]. This suggests that the minimal latency period to see the onset of aggressive tumors may have not been reached in our study or the number of animals studied is too low. We have been in the process of "aging" a cohort of Pdx1-Cre;LSL-KrasG12D;Tif1gammalox/lox mice to address this specific point even if we cannot rule out the possibility that these animals die before developing aggressive tumors because of pancreatic failure due to growing cysts. The molecular mechanism supporting the cooperation between activated KrasG12D mutation and Tif1gamma inactivation to induce the formation of IPMNs is still unknown. TAK1 (TGFbeta Associated Kinase 1), which has recently been proposed to explain R-Ras and TGFbeta cooperation in breast tumors, is an interesting candidate [36].
###end p 31
###begin p 32
###xml 172 176 165 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Heldin1">[37]</xref>
###xml 310 314 296 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Dupont1">[29]</xref>
###xml 315 319 301 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Dupont2">[30]</xref>
###xml 368 372 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-He1">[32]</xref>
###xml 758 765 726 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1496 1501 1448 1453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad4</italic>
###xml 1820 1824 1761 1765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-He1">[32]</xref>
###xml 1977 1981 1914 1918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Doisne1">[33]</xref>
###xml 2157 2166 2094 2099 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIF1&#947;</italic>
###xml 2172 2176 2105 2109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Jones1">[20]</xref>
###xml 2233 2242 2166 2171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIF1&#947;</italic>
###xml 2366 2375 2295 2300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIF1&#947;</italic>
###xml 2434 2438 2359 2363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Ng1">[38]</xref>
###xml 2456 2460 2381 2385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Sawyer1">[39]</xref>
###xml 2494 2498 2419 2423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Johansson1">[40]</xref>
###xml 2542 2546 2467 2471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Klugbauer1">[41]</xref>
###xml 2627 2636 2552 2557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif1&#945;</italic>
###xml 2682 2686 2603 2607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Khetchoumian1">[42]</xref>
###xml 3012 3016 2922 2926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Dupont1">[29]</xref>
###xml 3017 3021 2927 2931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Dupont2">[30]</xref>
###xml 1373 1378 <span type="species:ncbi:9606">human</span>
###xml 2645 2649 <span type="species:ncbi:10090">mice</span>
The relationship between TIF1gamma and SMAD4 and their respective role in TGFbeta signaling have been a subject of extensive investigation and debate in the last few years [37]. Indeed, published data support distinct models whereby TIF1gamma could function as either a negative regulator of TGFbeta signaling [29],[30] or a complementary agonist of TGFbeta signaling [32]. In the "antagonist model", TIF1gamma negative function relies on its ability to mono-ubiquitinate and relocate SMAD4 into the cytoplasm. In the "agonist model", TIF1gamma competes with SMAD4 for binding to SMAD2 and 3 and form TIF1gamma-SMAD2/3 complexes regulating SMAD4-independent TGFbeta responses. One can envision that these models, both supported by compelling biochemical and in vivo evidence, are not mutually exclusive and that one of them may be predominant depending on the cellular context. The experimental evidence we present here suggest that TIF1gamma works with SMAD4 as a complementary agonist molecule during pancreatic tumorigenesis. In the presence of activated Kras, Tif1gamma loss-of-function induces cystic lesions resembling those observed in the absence of Smad4 suggesting that both molecules act in concert to prevent tumor progression. Even if this hypothesis needs further demonstration, it is strengthened by the observation that TIF1gamma expression is decreased in human pancreatic tumors and our observation that loss of Tif1gamma does not significantly impair Smad4 expression level or Smad4 target genes expression (data not shown). The existence of a joint effort between TIF1gamma and SMAD4 to maintain TGFbeta-mediated tissue homeostasis has been proposed before. Indeed, during erythroid differentiation, TIF1gamma mediates the differentiation response while SMAD4 mediates the antiproliferative response [32]. In a recent work, we showed that Tif1gamma controlled iNKT (invariant Natural Killer T) cell expansion whereas Smad4 maintained their maturation state [33]. A recent comprehensive genetic analysis of >20,000 transcripts in 24 pancreatic cancers failed to identify point mutations, amplifications, deletion or translocations in the TIF1gamma gene [20]. The present study strongly spurs us toward looking for TIF1gamma genetic alterations in a larger set of pancreatic tumors. Besides, chromosomal breakpoints chromosome on 1p13.1 containing TIF1gamma gene have been reported in acute megakaryocytic leukemias [38], osteochondromas [39], bronchial large cell carcinomas [40] and childhood papillary thyroid carcinomas [41]. Interestingly, we recently demonstrated that abrogation of the closely related Tif1alpha gene in mice caused hepatocellular carcinoma [42]. These observations reinforce the idea according to which TIF1gamma loss of function could play an active protective role during tumorigenesis. TIF1gamma overexpression has been suggested by others to facilitate tumorigenesis in other organs by inhibiting SMAD4-mediated growth inhibition and motility in response to TGFbeta [29],[30]. This observation may reflect an active role of TIF1gamma during tumor progression depending on the organ and involving a anti-SMAD4 mechanisms ("antagonist" model).
###end p 32
###begin p 33
###xml 69 78 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif1&#947;</italic>
###xml 109 113 105 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 105 113 101 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras<sup>G12D</sup></italic>
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
In conclusion, we demonstrated in a mouse model that inactivation of Tif1gamma cooperates with activated KrasG12D to induce cystic pancreatic tumors. Characterization of new players involved in the outbreak of early pancreatic lesions that will eventually evolve into invasive pancreatic cancer is crucial to detect the disease earlier and eventually develop new therapeutic drugs. Further work to decipher the respective roles of SMAD4 and TIF1gamma in PDAC as well as the functional cooperation between KRAS and TIF1gamma could bring new insight into the etiology of pancreatic cancer, and generate a better understanding of the multifaceted role of TGFbeta in carcinogenesis and development.
###end p 33
###begin title 34
Materials and Methods
###end title 34
###begin title 35
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 35
###begin p 36
###xml 9 16 5 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 0 16 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif1&#947;<sup>lox/lox</sup></italic>
###xml 16 20 12 16 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-He1">[32]</xref>
###xml 176 180 172 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tif1</italic>
###xml 235 242 227 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PGK Neo</italic>
###xml 277 281 269 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP</italic>
###xml 329 333 321 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP</italic>
###xml 536 543 528 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PGK-Neo</italic>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
Tif1gammalox/lox[32] mice harboring floxed exons 2-4 were generated by K.Y. and R.L. will be described elsewhere. Briefly, using a genomic clone that contains a portion of the Tif1gamma gene, we generated a targeting vector in which a PGK Neo selection cassette flanked by two loxP sites was introduced into intron 1 and a third loxP site inserted into intron 4. This targeting vector was designed with the expectation that upon homologous recombination and subsequent Cre recombinase-mediated excision, exons 2, 3 and 4 along with the PGK-Neo cassette would be deleted, thereby causing a frameshift mutation with a premature termination codon in exon 5. The putative product of this deleted gene corresponds to a truncated protein lacking part of the RING finger-B box-coiled coil (RBCC) motif and the entire C-terminal region of the TIF1gamma protein, which contains the conserved PHD finger/bromodomain unit.
###end p 36
###begin p 37
###xml 9 16 9 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4A/Arf<sup>lox/lox</sup></italic>
###xml 16 20 16 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Aguirre1">[12]</xref>
###xml 30 34 30 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 22 34 22 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-Kras<sup>G12D</sup></italic>
###xml 34 37 34 37 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Hingorani1">[8]</xref>
###xml 39 43 39 43 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Jackson1">[43]</xref>
###xml 44 48 44 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Tuveson1">[45]</xref>
###xml 53 61 53 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre</italic>
###xml 61 65 61 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Gu1">[34]</xref>
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
###xml 122 126 <span type="species:ncbi:10090">Mice</span>
Ink4A/Arflox/lox[12], LSL-KrasG12D[8], [43]-[45] and Pdx1-Cre[34] mouse strains done by others were previously described. Mice were maintained in a specific pathogen-free animal facility at the "Centre Leon Berard" (Lyon, France) and handled in compliance with the institutional guidelines. All procedures were approved by an ethic committee under regulatory of governmental authority (CREEA).
###end p 37
###begin title 38
Histology
###end title 38
###begin p 39
###xml 61 65 61 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Treilleux1">[46]</xref>
###xml 357 361 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-AlboresSaavedra1">[47]</xref>
Histology experiments were performed as previously described [46]. Primary antibody used were : TIF1gamma (1/800; Euromedex), Chymotrypsin (1/1000; AbD Serotec), Insulin (1/1000; Dako), CK19 (1/10; Trauma III - Developmental Studies Hybridoma Bank - University of Iowa), SMAD4 (1/100; Santa Cruz). Alcian blue staining was performed as previously described [47].
###end p 39
###begin title 40
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human samples
###end title 40
###begin p 41
###xml 267 275 <span type="species:ncbi:9606">patients</span>
###xml 329 337 <span type="species:ncbi:9606">patients</span>
Cryopreserved tumoral and peritumoral tissue samples were obtained from an institutional tissue bank, the Tumorotheque des Hospices Civils de Lyon (Centre de Ressources Biologiques, Hospices Civils de Lyon). In accordance with French ethical rules, samples were from patients having given their informed consent or from deceased patients. Prior to molecular analysis, the quality and cellularity of tissue samples was verified histologically; tumor tissues were selected in order to contain a significant amount of neoplastic cells; peritumoral tissues were constantly altered by reactive fibrotic changes associated with a loss in acinar tissue and a massive ductular proliferation.
###end p 41
###begin title 42
RNA analysis
###end title 42
###begin p 43
###xml 316 320 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000575-Bartholin1">[48]</xref>
###xml 23 28 <span type="species:ncbi:9606">human</span>
Liquid nitrogen frozen human tumors were blended using a Pro200 homogenizer (Pro Scientific Inc.) in a 5 M guanidine solution. Total RNA was further purified by RNeasy mini kit (Qiagen). The cDNA was used as template with RT Kit SuperScript II (Invitrogen). quantitative RT-PCR was performed as previously described [48].
###end p 43
###begin title 44
Live imaging
###end title 44
###begin p 45
###xml 29 33 <span type="species:ncbi:10090">mice</span>
For MRI and PET experiments, mice were anesthetized using 3% isoflurane inhalation (TEM Sega, Lormont, France) and maintained in 1.5% isoflurane atmosphere during experiments.
###end p 45
###begin p 46
###xml 865 866 849 850 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 583 588 <span type="species:ncbi:10090">mouse</span>
For PET experiments, the mice were catherized in the caudal vein (24 gauge), injected with 250 microCi of 300 microL of radioactive 18-Fluorodeoxyglucose (FDG). After 90 minutes to allow FDG fixation, images were acquired during 15 minutes (constant 2% isoflurane atmosphere) using the "TEP clearPET" (Raytest, Inc.). MRI acquisitions were made with a BioSpec-7T system (Bruker, Ettlingen, Germany) using a 32 mm inner-diameter emission/reception volume coil (Rapid Biomedical, Wurzburg, Germany). T1/T2-weighted contrast sequences synchronized to respiration were acquired for each mouse. A RARE (Rapid Acquisition with Relaxation Enhancement) sequence (TR/TE 3500/38.1 ms) with fat saturation was used. Geometric parameters were: a series of 18, 750 microm thick sections, 33 mm field of view, and 256x256 pixel matrix. Voxel size was therefore 129x129x750 microm3.
###end p 46
###begin title 47
Supporting Information
###end title 47
###begin p 48
###xml 83 90 75 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 64 90 60 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre; Tif1&#947;<sup>lox/lox</sup></italic>
###xml 261 268 245 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 243 268 231 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre;TIF1&#947;<sup>lox/lox</sup></italic>
###xml 91 95 <span type="species:ncbi:10090">mice</span>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
Loss of nuclear Tif1gamma protein expression in the pancreas of Pdx1-Cre; Tif1gammalox/lox mice. Immunohistochemistry showed that Tif1gamma was expressed in the nuclei of pancreatic cells in wild-type mice and that this staining was lost in a Pdx1-Cre;TIF1gammalox/lox pancreas.
###end p 48
###begin p 49
(2.25 MB TIF)
###end p 49
###begin p 50
Click here for additional data file.
###end p 50
###begin p 51
###xml 68 72 68 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 83 90 79 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 50 90 50 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre; LSL-Kras<sup>G12D</sup>; Tif1&#947;<sup>lox/lox</sup></italic>
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
Image of a polycystic pancreas from a 154-day-old Pdx1-Cre; LSL-KrasG12D; Tif1gammalox/lox mouse. Pancreas is circled in black. Note the presence of numerous translucent cysts (arrowhead).
###end p 51
###begin p 52
(2.96 MB TIF)
###end p 52
###begin p 53
Click here for additional data file.
###end p 53
###begin p 54
###xml 228 232 228 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 243 250 239 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 210 250 210 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre; LSL-Kras<sup>G12D</sup>; Tif1&#947;<sup>lox/lox</sup></italic>
###xml 251 256 <span type="species:ncbi:10090">mouse</span>
Presence of inflammatory cells in the pancreas associated with the cystic structures. Immunohistochemistry revealed the presence of different populations of leucocytes infiltrating the pancreas of a 20-day-old Pdx1-Cre; LSL-KrasG12D; Tif1gammalox/lox mouse (D-F) compared to a wild-type littermate (A-C). MPO (A,D), F4/80 (B,E), and CD3 (C,F) were respectively used as specific markers for neutrophiles, macrophages and lymphocytes.
###end p 54
###begin p 55
(2.71 MB TIF)
###end p 55
###begin p 56
Click here for additional data file.
###end p 56
###begin p 57
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMAD4</italic>
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMAD4</italic>
###xml 211 216 211 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMAD4</italic>
###xml 20 25 <span type="species:ncbi:9606">human</span>
###xml 169 176 <span type="species:ncbi:9606">patient</span>
###xml 340 347 <span type="species:ncbi:9606">patient</span>
###xml 589 597 <span type="species:ncbi:9606">patients</span>
SMAD4 expression in human pancreatic neoplasia. Quantitative RT-PCR to detect SMAD4 expression from the 16 PDAC for which peritumoral tissue was available (A). For each patient represented by an individual bar, SMAD4 expression is represented as a percentage of variation relative to mRNA expression in the peritumoral tissue from the same patient (B). SMAD4 protein expression pattern was also assessed by immunohistochemistry. In the normal pancreas (C), SMAD4 is strongly detected in endocrine islets, a faint labeling is visible in acinar cells and ductal cells. In adenocarcinomas (n patients = 20), no labeling for SMAD4 was detected whereas adjacent residual endocrine cells are positive (D). In another example of adenocarcinoma, SMAD4 is faintly but readily detectable in neoplastic cells; the labeling is both cytoplasmic and nuclear (E). In IPMN grade 3, SMAD4 expression is heterogeneous; most cells are negative, while a few scattered cells retain a faint expression, usually nuclear (F). In PanIN grade 3, SMAD4 expression is either undetectable, as exemplified in the largest figure (note the persistent expression in adjacent residual endocrine cells (arrow)), or heterogeneous, as shown in the inset (G). In MCN, SMAD4 expression is usually strong, in low grade (large figure) as well as in high grade (inset) lesions (H).
###end p 57
###begin p 58
(3.34 MB TIF)
###end p 58
###begin p 59
Click here for additional data file.
###end p 59
###begin p 60
Measurement of the area occupied by the normal pancreatic tissue.
###end p 60
###begin p 61
(0.06 MB DOC)
###end p 61
###begin p 62
Click here for additional data file.
###end p 62
###begin p 63
###xml 292 299 292 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox/lox</sup>
###xml 283 299 283 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4A/Arf<sup>lox/lox</sup></italic>
###xml 309 313 309 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 301 313 301 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-Kras<sup>G12D</sup></italic>
###xml 319 327 319 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1-Cre</italic>
###xml 328 333 <span type="species:ncbi:10090">mouse</span>
We thank G. Gouysse, J.B. Langlois, S. Martin, M. Janier, P. Meeus, and M. Peix for their expert assistance. We are deeply grateful to D. Wotton for advice, helpful discussions, and proofreading of the manuscript. We thank T. Jacks/R. DePinho, D.Tuveson, and D. Melton for providing Ink4A/Arflox/lox, LSL-KrasG12D, and Pdx1-Cre mouse strains.
###end p 63
###begin title 64
References
###end title 64
###begin article-title 65
Pancreatic cancer.
###end article-title 65
###begin article-title 66
Precursors to invasive pancreatic cancer.
###end article-title 66
###begin article-title 67
Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study.
###end article-title 67
###begin article-title 68
Pancreatic carcinogenesis.
###end article-title 68
###begin article-title 69
Pancreatic cancer biology and genetics.
###end article-title 69
###begin article-title 70
Familial pancreatic cancer.
###end article-title 70
###begin article-title 71
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations.
###end article-title 71
###begin article-title 72
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.
###end article-title 72
###begin article-title 73
###xml 112 116 <span type="species:ncbi:10090">mice</span>
Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice.
###end article-title 73
###begin article-title 74
###xml 104 119 <span type="species:ncbi:10090">transgenic mice</span>
Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice.
###end article-title 74
###begin article-title 75
###xml 127 131 <span type="species:ncbi:10090">mice</span>
Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.
###end article-title 75
###begin article-title 76
Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.
###end article-title 76
###begin article-title 77
###xml 103 108 <span type="species:ncbi:10090">mouse</span>
Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse.
###end article-title 77
###begin article-title 78
###xml 47 51 <span type="species:ncbi:10090">mice</span>
Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression.
###end article-title 78
###begin article-title 79
Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms.
###end article-title 79
###begin article-title 80
###xml 110 115 <span type="species:ncbi:9606">human</span>
Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN.
###end article-title 80
###begin article-title 81
Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia.
###end article-title 81
###begin article-title 82
GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation.
###end article-title 82
###begin article-title 83
Loss of the Acinar-Restricted Transcription Factor Mist1 Accelerates Kras-Induced Pancreatic Intraepithelial Neoplasia.
###end article-title 83
###begin article-title 84
###xml 27 32 <span type="species:ncbi:9606">human</span>
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses.
###end article-title 84
###begin article-title 85
Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer.
###end article-title 85
###begin article-title 86
Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas.
###end article-title 86
###begin article-title 87
Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia.
###end article-title 87
###begin article-title 88
In vivo disruption of TGF-beta signaling by Smad7 leads to premalignant ductal lesions in the pancreas.
###end article-title 88
###begin article-title 89
How the Smads regulate transcription.
###end article-title 89
###begin article-title 90
The logic of TGFbeta signaling.
###end article-title 90
###begin article-title 91
TIF1gamma, a novel member of the transcriptional intermediary factor 1 family.
###end article-title 91
###begin article-title 92
###xml 69 74 <span type="species:ncbi:10090">mouse</span>
Molecular cloning, genomic structure, and expression analysis of the mouse transcriptional intermediary factor 1 gamma gene.
###end article-title 92
###begin article-title 93
Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase.
###end article-title 93
###begin article-title 94
FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination.
###end article-title 94
###begin article-title 95
Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation.
###end article-title 95
###begin article-title 96
Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway.
###end article-title 96
###begin article-title 97
iNKT cell development is orchestrated by different branches of TGF-beta signaling.
###end article-title 97
###begin article-title 98
Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors.
###end article-title 98
###begin article-title 99
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
An illustrated review of early pancreas development in the mouse.
###end article-title 99
###begin article-title 100
Transforming growth factor-beta (TGF-beta) and TGF-beta-associated kinase 1 are required for R-Ras-mediated transformation of mammary epithelial cells.
###end article-title 100
###begin article-title 101
A new twist in Smad signaling.
###end article-title 101
###begin article-title 102
Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation.
###end article-title 102
###begin article-title 103
Recurring breakpoints of 1p13 approximately p22 in osteochondroma.
###end article-title 103
###begin article-title 104
Karyotypic characterization of bronchial large cell carcinomas.
###end article-title 104
###begin article-title 105
The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas.
###end article-title 105
###begin article-title 106
Loss of Trim24 (Tif1alpha) gene function confers oncogenic activity to retinoic acid receptor alpha.
###end article-title 106
###begin article-title 107
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.
###end article-title 107
###begin article-title 108
###xml 75 79 <span type="species:ncbi:10090">mice</span>
Somatic activation of the K-ras oncogene causes early onset lung cancer in mice.[see comment].
###end article-title 108
###begin article-title 109
Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects.
###end article-title 109
###begin article-title 110
Dendritic cell infiltration and prognosis of early stage breast cancer.
###end article-title 110
###begin article-title 111
The foamy variant of pancreatic intraepithelial neoplasia.
###end article-title 111
###begin article-title 112
###xml 14 18 <span type="species:ncbi:10090">mice</span>
Generation of mice with conditionally activated transforming growth factor beta signaling through the TbetaRI/ALK5 receptor.
###end article-title 112
###begin p 113
The authors have declared that no competing interests exist.
###end p 113
###begin p 114
This work was supported by grants from, ARC 3891 (LB), INSERM "Avenir" program (LB), INCA "libre" (RR/LB, JYS, and JCM), INCA "plateforme" (LB and JCM), and Ligue Contre le Cancer (LB). DFV is a MENRT doctoral fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 114

